5-azacytidine improves the osteogenic differentiation potential of aged human adipose-derived mesenchymal stem cells by DNA demethylation.
The therapeutic value of adipose-derived mesenchymal stem cells (Ad-MSCs) for bone regeneration is critically discussed. A possible reason for reduced osteogenic potential may be an age-related deterioration of the Ad-MSCs. In long term in vitro culture, epigenomic changes in DNA methylation are kno...
Main Authors: | Xueying Yan, Sabrina Ehnert, Mihaela Culmes, Anastasia Bachmann, Claudine Seeliger, Lilianna Schyschka, Zhiyong Wang, Afshin Rahmanian-Schwarz, Ulrich Stöckle, Paul A De Sousa, Jaroslav Pelisek, Andreas K Nussler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3946260?pdf=render |
Similar Items
-
A Comparative Analysis of 5-Azacytidine- and Zebularine-Induced DNA Demethylation
by: Patrick T. Griffin, et al.
Published: (2016-09-01) -
The effects of the DNA Demethylating reagent, 5-azacytidine on SMCHD1 genomic localization
by: S. Massah, et al.
Published: (2020-01-01) -
Demethylation using the epigenetic modifier, 5-azacytidine, increases the efficiency of transient transfection of macrophages
by: Geneviève Escher, et al.
Published: (2005-02-01) -
Decrease of Global Methylation Improves Significantly Hepatic Differentiation of Ad-MSCs: Possible Future Application for Urea Detoxification
by: C. Seeliger, et al.
Published: (2013-01-01) -
Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines.
by: Sabine Hagemann, et al.
Published: (2011-01-01)